Inactive Instrument

Diaxonhit SA Share Price Euronext Paris

Equities

ALEHT

FR0013240934

Biotechnology & Medical Research

End-of-day quote Euronext Paris
- EUR - Intraday chart for Diaxonhit SA
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2023 130M 140M 11.69B Sales 2024 * 138M 149M 12.41B Capitalization 148M 160M 13.33B
Net income 2023 4M 4.31M 360M Net income 2024 * 9M 9.7M 809M EV / Sales 2023 1.29 x
Net Debt 2023 * 8.8M 9.48M 791M Net cash position 2024 * 9.9M 10.67M 890M EV / Sales 2024 * 1 x
P/E ratio 2023
38.3 x
P/E ratio 2024 *
15.3 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 61.3%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 19/17/19
Director of Finance/CFO 43 01/22/01
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 19/17/19
Director/Board Member 68 04/09/04
Director/Board Member 67 15/17/15
More insiders
Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 286 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW